Haemonetics Share Price

Haemonetics Share Price

NYSE: HAE | Mid Cap | Healthcare
$122.27
+$1.27 (1.05%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Haemonetics Stock Performance

Open
$120.60
Prev. Close
$121.00
Circuit Range
N/A
Day Range
$120.60 - $123.44
Year Range
$51.24 - $130.16
Volume
21,080
Average Traded
$122.68

Haemonetics Share Price Today

As of 19 November 2026, Haemonetics Corporation's share price is $122.27. The stock opened at $120.60, compared to its previous close of $121.00. During today's trading session, Haemonetics Corporation's share price traded between $120.60 and $123.44, with an average price of $122.02. Over the past 52 weeks, the stock has recorded a high of $130.16 and a low of $51.24. In terms of performance, Haemonetics Corporation's share price has risen by 79.95% over the last six months and is up 50.20% on a year-on-year basis.

Haemonetics Share Price Chart

Line chart of the Haemonetics price trend over the selected period. The price rose overall, ranging from 120.44 to 123.42, ending at 122.27.
$120.60$123.44
L
Show Current Price
H

Haemonetics Stock Fundamentals & Key Indicators

Market Cap
$6.15B
PE Ratio (TTM)
52.99
Dividend Yield
0.00%
EPS (TTM)
$2.28
Revenue (TTM)
$1.33T
Return On Equity (TTM)
11.56%
Profit Margin
7.29%
Debt to Equity
1.25
Quarterly Earnings Growth YoY
3.51%

Haemonetics Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$338.97$346.35$339.38$357.76
Net Profit$44.74-$20.15$33.01$46.31
Net Profit Margin13.20%-5.82%9.73%12.94%
Income ChangeN/A-145.04%263.82%40.29%

Haemonetics Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$1168.66$1309.06$1360.82$1334.03
Net Profit$115.40$117.56$167.68$97.31
Net Profit Margin9.87%8.98%12.32%7.29%
Income ChangeN/A1.87%42.63%-41.97%

Haemonetics Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets1561.051515.971426.691165.1
Current Assets834.88934.98768.9769.72
Total Assets2395.932450.952195.591934.83
Non Current Liabilities1317.011052.0935.25865.01
Current Liabilities282.6578.11300.38251.82
Total Liabilities1599.611630.111235.631116.83
Shareholders' Equity796.32820.84959.96818.0

Haemonetics Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating293.22181.73181.75273.06
Investing-179.55-161.9-322.39-143.79
Financing-178.46108.8238.16-100.36

About Haemonetics

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Haemonetics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$120.23
$122.00
+1.99%
Oct 2026
$105.58
$119.62
+13.30%
Sep 2026
$101.19
$105.58
+0.56%
Aug 2026
$86.34
$104.99
+22.64%
Jul 2026
$75.88
$85.61
+13.87%
Jun 2026
$66.11
$75.18
+10.65%
May 2026
$59.77
$67.94
+13.17%
Apr 2026
$56.48
$60.04
+6.61%
Mar 2026
$63.02
$56.32
-10.98%
Feb 2026
$66.16
$63.27
-5.09%
Jan 2026
$80.53
$66.66
-16.77%
Dec 2025
$81.56
$80.09
-1.62%

Haemonetics Share Price FAQs